| P2093 | author name string | F Schneider | |
| | C P Muller | |
| | F Berthet | |
| | F Bouche | |
| | S Houard | |
| | W Ammerlaan | |
| P2860 | cites work | Role of virus strain dm conventional and enhanced measles plaque neutralization test | Q45791537 |
| | Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity | Q45848581 |
| | Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. | Q52895150 |
| | The 1st International Standard for anti-measles serum. | Q53399096 |
| | Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response | Q70333506 |
| | Maternal measles and rubella antibody levels and serologic response in infants immunized with MMR II vaccine at 12 months of age | Q72620765 |
| | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | A new generation of animal cell expression vectors based on the Semliki Forest virus replicon | Q30014839 |
| | Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein | Q33554501 |
| | Measles antibody: reevaluation of protective titers | Q34251667 |
| | Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines | Q34289089 |
| | Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity | Q34407452 |
| | Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition | Q36231571 |
| | Immune reactivity of the purified hemagglutinin of measles virus | Q36448643 |
| | Measles virus haemagglutinin gene: cloning, complete nucleotide sequence analysis and expression in COS cells | Q36481562 |
| | Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody | Q36520317 |
| | Measles virus nucleocapsid protein protects rats from encephalitis | Q36683453 |
| | Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein | Q36686798 |
| | Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge | Q36784384 |
| | Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge | Q36797309 |
| | Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene | Q36798265 |
| | Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. | Q36920330 |
| | Performance and reliability of the Enzygnost measles enzyme-linked immuno-sorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic | Q37117158 |
| | Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. | Q37239980 |
| | Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays | Q37249605 |
| | Enzyme-linked immunosorbent assay for detection of measles antibody | Q37306741 |
| | Measles active and passive immunity in a worldwide perspective. | Q38727164 |
| | High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system | Q40130193 |
| | Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status | Q40203959 |
| | Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus | Q40217832 |
| | Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. | Q40221648 |
| | Cytotoxic T cells in paramyxovirus infection of humans. | Q40631681 |
| | Cytotoxic T lymphocyte responses against measles virus | Q40631688 |
| | Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein | Q41362174 |
| | CD4+ T cells control measles virus infection of the central nervous system | Q41622477 |
| | Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice | Q41641670 |
| | Production of measles nucleoprotein in different expression systems and its use as a diagnostic reagent | Q42067815 |
| | Characterization of baculovirus-expressed hemagglutinin and fusion glycoproteins of the attenuated measles virus strain AIK-C | Q42070845 |
| | Use of Concentrated Human Serum gamma-Globulin in the Prevention and Attenuation of Measles | Q42080455 |
| | Expression of the measles virus nucleoprotein gene in Escherichia coli and assembly of nucleocapsid-like structures | Q43805029 |
| | Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins | Q44117284 |
| | Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis | Q44249267 |
| | Monoclonal Antibodies Against Measles Virus | Q45022489 |
| | Monospecific Antibody to the Haemagglutinin of Measles Virus | Q45066557 |
| | Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure | Q45195047 |
| | Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors | Q45760192 |
| | Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein | Q45778631 |
| | Intracellular processing and antigenic maturation of measles virus hemagglutinin protein | Q45789794 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | measles | Q79793 |
| P304 | page(s) | 721-726 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity | |
| P478 | volume | 36 | |